Your browser doesn't support javascript.
loading
Characterizing the Genetic Architecture of Parkinson's Disease in Latinos.
Loesch, Douglas P; Horimoto, Andrea R V R; Heilbron, Karl; Sarihan, Elif I; Inca-Martinez, Miguel; Mason, Emily; Cornejo-Olivas, Mario; Torres, Luis; Mazzetti, Pilar; Cosentino, Carlos; Sarapura-Castro, Elison; Rivera-Valdivia, Andrea; Medina, Angel C; Dieguez, Elena; Raggio, Victor; Lescano, Andres; Tumas, Vitor; Borges, Vanderci; Ferraz, Henrique B; Rieder, Carlos R; Schumacher-Schuh, Artur; Santos-Lobato, Bruno L; Velez-Pardo, Carlos; Jimenez-Del-Rio, Marlene; Lopera, Francisco; Moreno, Sonia; Chana-Cuevas, Pedro; Fernandez, William; Arboleda, Gonzalo; Arboleda, Humberto; Arboleda-Bustos, Carlos E; Yearout, Dora; Zabetian, Cyrus P; Cannon, Paul; Thornton, Timothy A; O'Connor, Timothy D; Mata, Ignacio F.
  • Loesch DP; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD.
  • Horimoto ARVR; Program in Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, MD.
  • Heilbron K; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
  • Sarihan EI; Department of Biostatistics, University of Washington, Seattle, WA.
  • Inca-Martinez M; 23andMe, Inc., Sunnyvale, CA.
  • Mason E; Lerner Research Institute, Genomic Medicine, Cleveland Clinic, Cleveland, OH.
  • Cornejo-Olivas M; Lerner Research Institute, Genomic Medicine, Cleveland Clinic, Cleveland, OH.
  • Torres L; Lerner Research Institute, Genomic Medicine, Cleveland Clinic, Cleveland, OH.
  • Mazzetti P; Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Cosentino C; Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Sarapura-Castro E; Movement Disorders Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Rivera-Valdivia A; School of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Medina AC; Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Dieguez E; School of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Raggio V; Movement Disorders Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Lescano A; School of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Tumas V; Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Borges V; Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Ferraz HB; Universidad Nacional del Altiplano, Puno, Peru.
  • Rieder CR; Neurology Institute, Universidad de la República, Montevideo, Uruguay.
  • Schumacher-Schuh A; Department of Genetics, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
  • Santos-Lobato BL; Neurology Institute, Universidad de la República, Montevideo, Uruguay.
  • Velez-Pardo C; Ribeirão Preto Medical School, Universidade de São Paulo, Ribeirão Preto, Brazil.
  • Jimenez-Del-Rio M; Movement Disorders Unit, Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Lopera F; Movement Disorders Unit, Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Moreno S; Departamento de Neurologia, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
  • Chana-Cuevas P; Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Fernandez W; Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Arboleda G; Instituto de Ciências da Saúde, Universidade Federal do Pará, Belém, Brazil.
  • Arboleda H; Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, Universidad de Antioquia (UdeA), Medellín, Colombia.
  • Arboleda-Bustos CE; Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, Universidad de Antioquia (UdeA), Medellín, Colombia.
  • Yearout D; Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, Universidad de Antioquia (UdeA), Medellín, Colombia.
  • Zabetian CP; Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, Universidad de Antioquia (UdeA), Medellín, Colombia.
  • Cannon P; Neuroscience and Cell Death Research Groups, Medical School and Genetic Institute, Universidad Nacional de Colombia, Bogotá, Colombia.
  • Thornton TA; Neuroscience and Cell Death Research Groups, Medical School and Genetic Institute, Universidad Nacional de Colombia, Bogotá, Colombia.
  • O'Connor TD; Neuroscience and Cell Death Research Groups, Medical School and Genetic Institute, Universidad Nacional de Colombia, Bogotá, Colombia.
  • Mata IF; Neuroscience and Cell Death Research Groups, Medical School and Genetic Institute, Universidad Nacional de Colombia, Bogotá, Colombia.
Ann Neurol ; 90(3): 353-365, 2021 09.
Article en En | MEDLINE | ID: mdl-34227697
ABSTRACT

OBJECTIVE:

This work was undertaken in order to identify Parkinson's disease (PD) risk variants in a Latino cohort, to describe the overlap in the genetic architecture of PD in Latinos compared to European-ancestry subjects, and to increase the diversity in PD genome-wide association (GWAS) data.

METHODS:

We genotyped and imputed 1,497 PD cases and controls recruited from nine clinical sites across South America. We performed a GWAS using logistic mixed models; variants with a p-value <1 × 10-5 were tested in a replication cohort of 1,234 self-reported Latino PD cases and 439,522 Latino controls from 23andMe, Inc. We also performed an admixture mapping analysis where local ancestry blocks were tested for association with PD status.

RESULTS:

One locus, SNCA, achieved genome-wide significance (p-value <5 × 10-8 ); rs356182 achieved genome-wide significance in both the discovery and the replication cohorts (discovery, G allele 1.58 OR, 95% CI 1.35-1.86, p-value 2.48 × 10-8 ; 23andMe, G allele 1.26 OR, 95% CI 1.16-1.37, p-value 4.55 × 10-8 ). In our admixture mapping analysis, a locus on chromosome 14, containing the gene STXBP6, achieved significance in a joint test of ancestries and in the Native American single-ancestry test (p-value <5 × 10-5 ). A second locus on chromosome 6, containing the gene RPS6KA2, achieved significance in the African single-ancestry test (p-value <5 × 10-5 ).

INTERPRETATION:

This study demonstrated the importance of the SNCA locus for the etiology of PD in Latinos. By leveraging the demographic history of our cohort via admixture mapping, we identified two potential PD risk loci that merit further study. ANN NEUROL 2021;90353-365.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Variación Genética / Hispánicos o Latinos / Estudio de Asociación del Genoma Completo / Sitios Genéticos Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: America do sul Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Variación Genética / Hispánicos o Latinos / Estudio de Asociación del Genoma Completo / Sitios Genéticos Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: America do sul Idioma: En Año: 2021 Tipo del documento: Article